ATRS - Antares Pharma, Inc.

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Currency in USD
Earnings EstimateCurrent Qtr. (Dec 2019)Next Qtr. (Mar 2020)Current Year (2019)Next Year (2020)
No. of Analysts6466
Avg. Estimate00.01-0.040.15
Low Estimate0-0.02-0.050.01
High Estimate0.010.04-0.030.28
Year Ago EPS0.04-0.03-0.04-0.04
Revenue EstimateCurrent Qtr. (Dec 2019)Next Qtr. (Mar 2020)Current Year (2019)Next Year (2020)
No. of Analysts6366
Avg. Estimate32.5M31.7M118.12M157.75M
Low Estimate30.2M26.9M116.3M145.82M
High Estimate36.9M35.7M120M174.5M
Year Ago Sales18.82M23.29M63.55M118.12M
Sales Growth (year/est)72.70%36.10%85.90%33.60%
Earnings History12/30/20183/30/20196/29/20199/29/2019
EPS Est.-0.02-0.04-0.04-0.02
EPS Actual0.04-0.03-0.010.01
Difference0.060.010.030.03
Surprise %300.00%25.00%75.00%150.00%
EPS TrendCurrent Qtr. (Dec 2019)Next Qtr. (Mar 2020)Current Year (2019)Next Year (2020)
Current Estimate00.01-0.040.15
7 Days Ago00.01-0.040.15
30 Days Ago00.01-0.050.15
60 Days Ago-0.010.03-0.080.16
90 Days Ago-0.010.03-0.080.16
EPS RevisionsCurrent Qtr. (Dec 2019)Next Qtr. (Mar 2020)Current Year (2019)Next Year (2020)
Up Last 7 Days1N/A1N/A
Up Last 30 DaysN/AN/AN/AN/A
Down Last 7 DaysN/AN/AN/AN/A
Down Last 30 DaysN/AN/AN/AN/A
Growth EstimatesATRSIndustrySectorS&P 500
Current Qtr.-100.00%N/AN/A0.01
Next Qtr.133.30%N/AN/A0.06
Current YearN/AN/AN/A-0.03
Next Year475.00%N/AN/A0.14
Next 5 Years (per annum)78.90%N/AN/A0.07
Past 5 Years (per annum)N/AN/AN/AN/A